XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.0.1
Unaudited Consolidated Statements of Operations and Comprehensive Income - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 6 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2021
Dec. 31, 2020
Revenues:        
Recurring and other revenue $ 195,041 $ 145,393 $ 375,865 $ 280,268
Interest income on funds held for clients 996 936 1,869 1,855
Total revenues 196,037 146,329 377,734 282,123
Cost of revenues 70,821 53,542 134,070 102,922
Gross profit 125,216 92,787 243,664 179,201
Operating expenses:        
Sales and marketing 52,219 37,775 102,104 75,449
Research and development 25,278 19,338 48,354 37,985
General and administrative 39,581 29,323 74,816 55,967
Total operating expenses 117,078 86,436 225,274 169,401
Operating income 8,138 6,351 18,390 9,800
Other expense (372) (379) (489) (636)
Income before income taxes 7,766 5,972 17,901 9,164
Income tax benefit (2,087) (3,670) (22,884) (12,938)
Net income 9,853 9,642 40,785 22,102
Other comprehensive loss, net of tax (335) (187) (410) (410)
Comprehensive income $ 9,518 $ 9,455 $ 40,375 $ 21,692
Net income per share:        
Basic (in dollars per share) $ 0.18 $ 0.18 $ 0.74 $ 0.41
Diluted (in dollars per share) $ 0.17 $ 0.17 $ 0.72 $ 0.39
Weighted-average shares used in computing net income per share:        
Basic (in shares) 55,067 54,305 54,938 54,160
Diluted (in shares) 56,468 56,343 56,486 56,122